HEALTH CATALYST INC - NOTE 2.500% 4/1

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Debt / NOTE 2.500% 4/1
Market price (% of par)
87.32%
Total 13F principal
$209,972,536
Principal change
+$6,655,000
Total reported market value
$204,357,832
Number of holders
24
Value change
+$4,958,688
Number of buys
8
Number of sells
8

Institutional Holders of HEALTH CATALYST INC - NOTE 2.500% 4/1 as of Q4 2022

As of 31 Dec 2022, HEALTH CATALYST INC - NOTE 2.500% 4/1 was held by 24 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $209,972,536 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MARSHALL WACE, LLP, LAZARD ASSET MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Opti Capital Management, LP, SILVERBACK ASSET MANAGEMENT LLC, Shaolin Capital Management LLC, and TENOR CAPITAL MANAGEMENT Co., L.P.. This page lists 24 institutional bondholders reporting positions for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.